Literature DB >> 29417255

On chronic fatigue syndrome and nosological categories.

Kassem Sharif1,2, Abdulla Watad1,2, Nicola Luigi Bragazzi3, Michael Lichtbroun1,2, Mariano Martini4, Carlo Perricone4,5, Howard Amital1,2, Yehuda Shoenfeld6,7.   

Abstract

Chronic fatigue syndrome (CFS) is a heterogeneous disease which presents with pronounced disabling fatigue, sleep disturbances, and cognitive impairment that negatively affects patients' functional capability. CFS remains a poorly defined entity and its etiology is still in question. CFS is neither a novel diagnosis nor a new medical condition. From as early as the eighteenth century, a constellation of perplexing symptoms was observed that resembled symptoms of CFS. Commencing with "febricula" and ending with CFS, many names for the disease were proposed including neurocirculatory asthenia, atypical poliomyelitis, Royal Free disease, effort syndrome, Akureyri disease, Tapanui disease, chronic Epstein-Barr virus syndrome, and myalgic encephalitis. To date, it remains unclear whether CFS has an autoimmune component or is a condition that precedes a full-blown autoimmune disease. Research suggests that CFS may overlap with other diseases including postural orthostatic tachycardia syndrome (POTS), autoimmune syndrome induced by adjuvants (ASIA), and Sjögren's syndrome. Additionally, it has been postulated that the earliest manifestations of some autoimmune diseases can present with vague non-specific symptoms similar to CFS. Sometimes only when exposed to a secondary stimulus (e.g., antigen) which could accelerate the natural course of the disease would an individual develop the classic autoimmune disease. Due to the similarity of symptoms, it has been postulated that CFS could simply be an early manifestation of an autoimmune disease. This paper will provide a historical background review of this disease and a discussion of CFS as an entity overlapping with multiple other conditions.

Entities:  

Keywords:  Autoimmune syndrome induced by adjuvants; Chronic fatigue syndrome; Myalgic encephalomyelitis; Postural orthostatic tachycardia syndrome

Mesh:

Year:  2018        PMID: 29417255     DOI: 10.1007/s10067-018-4009-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  53 in total

1.  Chronic fatigue syndrome: a working case definition.

Authors:  G P Holmes; J E Kaplan; N M Gantz; A L Komaroff; L B Schonberger; S E Straus; J F Jones; R E Dubois; C Cunningham-Rundles; S Pahwa
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

Review 2.  The postural tachycardia syndrome: a concise guide to diagnosis and management.

Authors:  Blair P Grubb; Yousuf Kanjwal; Daniel J Kosinski
Journal:  J Cardiovasc Electrophysiol       Date:  2006-01

3.  A disease epidemic in Iceland simulating poliomyelitis.

Authors:  B SIGURDSSON; J SIGURJONSSON; J H SIGURDSSON; J THORKELSSON; K R GUDMUNDSSON
Journal:  Am J Hyg       Date:  1950-09

Review 4.  Postviral fatigue syndrome: time for a new approach.

Authors:  A S David; S Wessely; A J Pelosi
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-05

5.  A reboot for chronic fatigue syndrome research.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2018-01       Impact factor: 49.962

6.  Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression.

Authors:  R Wheatland
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

Review 7.  Chronic fatigue syndrome: a systematic review.

Authors:  D Maquet; C Demoulin; J M Crielaard
Journal:  Ann Readapt Med Phys       Date:  2006-04-19

8.  An unexplained illness in West Otago.

Authors:  M Poore; P Snow; C Paul
Journal:  N Z Med J       Date:  1984-06-13

9.  Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA).

Authors:  Nancy Agmon-Levin; Yaron Zafrir; Shaye Kivity; Ari Balofsky; Howard Amital; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 4.505

10.  The relationship between fatigue and psychiatric disorders: evidence for the concept of neurasthenia.

Authors:  Samuel B Harvey; Simon Wessely; Diana Kuh; Matthew Hotopf
Journal:  J Psychosom Res       Date:  2009-03-03       Impact factor: 3.006

View more
  16 in total

1.  Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary.

Authors:  Spencer Richman; Matthew C Morris; Gordon Broderick; Travis J A Craddock; Nancy G Klimas; Mary Ann Fletcher
Journal:  Clin Ther       Date:  2019-03-11       Impact factor: 3.393

2.  Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology.

Authors:  Olga V Danilenko; Natalia Y Gavrilova; Leonid P Churilov
Journal:  Pathophysiology       Date:  2022-05-25

3.  Separating Patients with SEID from Those with CFS in the French ME/CFS Association, with Some Thoughts on Nomenclature.

Authors:  Julien Campagne; Isabelle Fornasieri; Barbara Andreani; Monique Eginard; Jean-Dominique de Korwin
Journal:  Diagnostics (Basel)       Date:  2022-04-27

4.  Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population.

Authors:  Thomas Khoo; Susanna Proudman; Vidya Limaye
Journal:  Clin Rheumatol       Date:  2019-01-31       Impact factor: 2.980

5.  Predicting GP visits: A multinomial logistic regression investigating GP visits amongst a cohort of UK patients living with Myalgic encephalomyelitis.

Authors:  R Stephen Walsh; Andrew Denovan; Kenneth Drinkwater; Sean Reddington; Neil Dagnall
Journal:  BMC Fam Pract       Date:  2020-06-10       Impact factor: 2.497

Review 6.  Potential Role of Neuroactive Tryptophan Metabolites in Central Fatigue: Establishment of the Fatigue Circuit.

Authors:  Masatoshi Yamashita
Journal:  Int J Tryptophan Res       Date:  2020-06-29

Review 7.  Glial Activation and Expression of the Serotonin Transporter in Chronic Fatigue Syndrome.

Authors:  Mami Noda; Masataka Ifuku; Md Shamim Hossain; Toshihiko Katafuchi
Journal:  Front Psychiatry       Date:  2018-11-16       Impact factor: 4.157

8.  A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review.

Authors:  Tiago Teodoro; Mark J Edwards; Jeremy D Isaacs
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-05-07       Impact factor: 10.154

9.  Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.

Authors:  Ingrid G Rekeland; Alexander Fosså; Asgeir Lande; Irini Ktoridou-Valen; Kari Sørland; Mari Holsen; Karl J Tronstad; Kristin Risa; Kine Alme; Marte K Viken; Benedicte A Lie; Olav Dahl; Olav Mella; Øystein Fluge
Journal:  Front Med (Lausanne)       Date:  2020-04-29

10.  Evaluation of the Reliability and Validity of the Persian Version of the Fatigue Assessment Scale in Iranian Sarcoidosis Patients.

Authors:  Somayeh Lookzadeh; Arda Kiani; Kimia Taghavi; Shirin Kianersi; Habib Emami; Maryam Mirenayat; Atefeh Abedini
Journal:  Open Access Maced J Med Sci       Date:  2018-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.